Z-1652-2022 Class II Ongoing
FDA device recall Z-1652-2022 was initiated by Qiagen Sciences LLC on Jul 20, 2022 and is designated Class II. Reason for recall: Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to… The recall status is ongoing. Affected quantity: 9 kits.
Recall details
- Product Type
- Devices
- Report Date
- Sep 7, 2022
- Initiation Date
- Jul 20, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9 kits
Product description
FGFR RGQ RT-PCR Kit (RUO, not IVD) REF 8747010
Reason for recall
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Distribution pattern
IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand
Code information
Lot number: 169047135 Exp Date: 12.06.2022 172017806 Exp. Date: 10.11.2022
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1652-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026